MENU

Department of Cancer Genome Research

Member

You can scroll horizontally.

Chief (Principal Investigator) Hirofumi Nakaoka, Ph.D. e-mail: h-nakaoka
Research Scientist
Research Assistant Keiko Nishikawa e-mail: k-nishikawa
Collabolator

*Please add @po.kyoundo.jp after e-mail address

Overview

Projects

Publications

Last 5 years

  1. Toyoda Y, Kawamura Y, Nakayama A, Nakaoka H, Higashino T, Shimizu S, Ooyama H, Morimoto K, Uchida N, Shigesawa R, Takeuchi K, Inoue I, Ichida K, Suzuki H, Shinomiya N, Takada T, Matsuo H: Substantial anti-gout effect conferred by common and rare dysfunctional variants of URAT1/SLC22A12. Rheumatology 60: 5224-5232, 2021.
  2. Tamura R, Yoshihara K, Matsuo K, Yachida N, Miyoshi A, Takahashi K, Sugino K, Yamaguchi M, Mori Y, Suda K, Ishiguro T, Okuda S, Motoyama T, Nakaoka H, Kikuchi A, Ueda Y, Inoue I, and Enomoto T: Proposing a molecular classification associated with hypercoagulation in ovarian clear cell carcinoma. Gynecol. Oncol. 163: 327-333, 2021.
  3. Sugimoto R, Nishimura L, Nguyen PT, Ito J, Parrish NF, Mori H, Kurokawa K, Nakaoka H, Inoue I: Comprehensive discovery of CRISPR-targeted terminally redundant sequences in the human gut metagenome: Viruses, plasmids, and more. PLoS Comput. Biol. 17: e1009428, 2021.
  4. Aamer W, Hassan HY, Nakaoka H, Hosomichi K, Jaeger M, Tahir H, Abdelraheem MH, Netea MG, and Inoue I: Analysis of HLA gene polymorphisms in East Africans reveals evidence of gene flow in two Semitic populations from Sudan. Eur. J. Hum. Genet. 29: 1259-1271, 2021.
  5. Yachida N, Yoshihara K, Suda K, Nakaoka H, Ueda H, Sugino K, Yamaguchi M, Mori Y, Yamawaki K, Tamura R, Ishiguro T, Kase H, Motoyama T, and Enomoto T: Biological significance of KRAS mutant allele expression in ovarian endometriosis. Cancer Sci. 112(5): 2020-2032, 2021.
  6. Yamaguchi M, Yoshihara K, Suda K, Nakaoka H, Yachida N, Ueda H, Sugino K, Mori Y, Yamawaki K, Tamura R, Ishiguro T, Motoyama T, Watanabe Y, Okuda S, Tainaka K, and Enomoto T: Three-dimensional understanding of the morphological complexity of the human uterine endometrium. iScience. 24(4): 102258, 2021.
  7. Matsumoto Y, Nagayama H, Nakaoka H, Toyoda A, Goto T, and Koide T: Combined change of behavioral traits for domestication and gene-networks in mice selectively bred for active tameness. Genes Brain Behav. 20(3): e12721, 2021.
  8. Nishimura L, Sugimoto R, Inoue J, Nakaoka H, Kanzawa-Kiriyama H, Shinoda KI, and Inoue I: Identification of ancient viruses from metagenomic data of the Jomon people. J. Hum. Genet. 66(3): 287-296, 2021.
  9. Nakakura S, Hosomichi K, Uchino S, Murakami A, Oka A, Inoue I, and Nakaoka H: HLA-B*39:01:01 is a novel risk factor for antithyroid drug-induced agranulocytosis in Japanese population. Pharmacogenomics J. 21(1): 94-101, 2021.
  10. Revathidevi S, Murugan AK, Nakaoka H, Inoue I, and Munirajan AK: APOBEC: A molecular driver in cervical cancer pathogenesis. Cancer Lett. 496: 104-116, 2021.
  11. Han B, Lee-Okada HC, Ishimine M, Orita H, Nishikawa K, Takagaki T, Kajino K, Yokomizo T, Hino O, and Kobayashi T: Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells. FEBS Open Bio. 10(11):2375-2387, 2020.
  12. Yesbolatova A, Saito Y, Kitamoto N, Makino-Itou H, Ajima R, Nakano R, Nakaoka H, Fukui K, Gamo K, Tominari Y, Takeuchi H, Saga Y, Hayashi K, and Kanemaki MT: The auxin-inducible degron 2 technology gives superior degradation control in yeast, mammalian cells, and mice. Nat. Commun. 11(1): 5701, 2020.
  13. Ito J, Kimura I, Soper A, Coudray A, Koyanagi Y, Nakaoka H, Inoue I, Turelli P, Trono D, and Sato K: Endogenous retroviruses drive KRAB zinc-finger protein family expression for tumor suppression. Sci. Adv. 6(43): eabc3020, 2020.
  14. Yachida N, Yoshihara K, Suda K, Nakaoka H, Ueda H, Sugino K, Yamaguchi M, Mori Y, Yamawaki K, Tamura R, Ishiguro T, Isobe M, Motoyama T, Inoue I, and Enomoto T: ARID1A protein expression is retained in ovarian endometriosis with ARID1A loss-of-function mutations: Implication for the two-hit hypothesis. Sci. Rep. 10(1): 14260, 2020.
  15. Kantake M, Ikeda N, Nakaoka H, Ohkawa N, Tanaka T, Miyabayashi K, Shoji H, and Shimizu T: IGF1 gene is epigenetically activated in preterm infants with intrauterine growth restriction. Clin. Epigenetics. 12(1): 108, 2020.
  16. Suda K, Cruz Diaz LA, Yoshihara K, Nakaoka H, Yachida N, Motoyama T, Inoue I, and Enomoto T: Clonal lineage from normal endometrium to ovarian clear cell carcinoma through ovarian endometriosis. Cancer Sci. 111(8): 3000–3009, 2020.
  17. Hata C, Nakaoka H, Xiang Y, Wang D, Yang A, Liu D, Liu F, Zou Q, Wei L, Zheng K, Inoue I, and You H: Germline mutations of multiple breast cancer-related genes are differentially associated with triple-negative breast cancers and prognostic factors. J. Hum. Genet. 65(7):577-587, 2020.
  18. Nakayama A*, Nakatochi M*, Kawamura Y*, Yamamoto K*, Nakaoka H*, Shimizu S, Higashino T, Koyama T, Hishida A, Kuriki K, Watanabe M, Shimizu T, Ooyama K, Ooyama H, Nagase M, Hidaka Y, Matsui D, Tamura T, Nishiyama T, Shimanoe C, Katsuura-Kamano S, Takashima N, Shirai Y, Kawaguchi M, Takao M, Sugiyama R, Takada Y, Nakamura T, Nakashima H, Tsunoda M, Danjoh I, Hozawa A, Hosomichi K, Toyoda Y, Kubota Y, Takada T, Suzuki H, Stiburkova B, Major TJ, Merriman TR, Kuriyama N, Mikami H, Takezaki T, Matsuo K, Suzuki S, Hosoya T, Kamatani Y, Kubo M, Ichida K, Wakai K, Inoue I, Okada Y, Shinomiya N, and Matsuo H on behalf of Japan Gout Genomics Consortium (Japan Gout). Subtype-specific gout susceptibility loci and enrichment of selection pressure on ABCG2 and ALDH2 identified by subtype genome-wide meta-analyses of clinically-defined gout patients. Ann Rheum Dis. 79(5):657-665, 2020. *Co-first author.
  19. Tamura R, Yoshihara K, Nakaoka H, Yachida N, Yamaguchi M, Suda K, Ishiguro T, Nishino K, Ichikawa H, Honma K, Kikuchi A, Ueda Y, Takei Y, Fujiwara H, Motoyama T, Okuda S, Wakai T, Inoue I, and Enomoto T. XCL1 expression correlates with CD8 positive T cells infiltration and PD-L1 expression in squamous cell carcinoma arising from mature cystic teratoma of the ovary. Oncogene. 39(17):3541-3554, 2020.
  20. Higashino T*, Morimoto K*, Nakaoka H*, Toyoda Y*, Kawamura Y*, Shimizu S*, Nakamura T, Hosomichi K, Nakayama A, Ooyama K, Ooyama H, Shimizu T, Ueno M, Ito T, Tamura T, Naito M, Nakashima H, Kawaguchi M, Takao M, Kawai Y, Osada N, Ichida K, Yamamoto K, Suzuki H, Shinomiya N, Inoue I, Takada T, and Matsuo H. Dysfunctional missense variant of OAT10/SLC22A13 decreases gout risk and serum uric acid levels. Ann. Rheum. Dis. 79(1):164-166, 2020.*Co-first author.
  21. Zhang S, Kohira Y, Orita H, Ishimine M, Kobayashi T, Chua SMB, Nakaoka H, Inoue I, Hino O, Yokomizo T, Fukunaga T, and Lee-Okada HC. Sensitization of gastric cancer cells to irinotecan by p53 activation. BPB Rep. 2: 130-133, 2019.
  22. Sugino K, Tamura R, Nakaoka H, Yachida N, Yamaguchi M, Mori Y, Yamawaki K, Suda K, Ishiguro T, Adachi S, Isobe M, Yamaguchi M, Kashima K, Motoyama T, Inoue I, Yoshihara K, and Enomoto T. Germline and somatic mutations of homologous recombination-associated genes in Japanese ovarian cancer patients. Sci. Rep. 9(1):17808, 2019.
  23. Suda K, Nakaoka H, Yoshihara K, Ishiguro T, Adachi S, Kase H, Motoyama T, Inoue I, and Enomoto T. Different mutation profiles between epithelium and stroma in endometriosis and normal endometrium. Hum. Reprod. 34(10):1899-1905, 2019.
  24. Hata C, Nakaoka H, Xiang Y, Wang D, Yang A, Liu D, Liu F, Zou Q, Zheng K, Inoue I, and You H. Exploration of intermediate-sized indels by next-generation multigene panel testing in Han Chinese patients with breast cancer. Hum. Genome Var.. 6:51, 2019.
  25. Kawamura Y*, Nakaoka H*, Nakayama A*, Okada Y*, Yamamoto K*, Higashino T, Sakiyama M, Shimizu T, Ooyama H, Ooyama K, Nagase M, Hidaka Y, Shirahama Y, Hosomichi K, Nishida Y, Shimoshikiryo I, Hishida A, Katsuura-Kamano S, Shimizu S, Kawaguchi M, Uemura H, Ibusuki R, Hara M, Naito M, Takao M, Nakajima M, Iwasawa S, Nakashima H, Ohnaka K, Nakamura T, Stiburkova B, Merriman TR, Nakatochi M, Ichihara S, Yokota M, Takada T, Saitoh T, Kamatani Y, Takahashi A, Arisawa K, Takezaki T, Tanaka K, Wakai K, Kubo M, Hosoya T, Ichida K, Inoue I, Shinomiya N, and Matsuo H. Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout. Ann. Rheum. Dis. 78(10):1430-1437, 2019. *Co-first author.
  26. Suda K, Nakaoka H, Hata C, Yahata N, Isobe M, Kameyama H, Wakai T, Motoyama T, Inoue I, Yoshihara K, and Enomoto T. Concurrent isolated retroperitoneal HGSC and STIC defined by somatic mutation analysis: a case report. Diagn. Pathol. 14(1):17, 2019.
  27. Hirata J, Hosomichi K, Sakaue S, Kanai M, Nakaoka H, Ishigaki K, Suzuki K, Akiyama M, Kishikawa T, Ogawa K, Masuda T, Yamamoto K, Hirata M, Matsuda K, Momozawa Y, Inoue I, Kubo M, Kamatani Y, and Okada Y. Genetic and phenotypic landscape of the major histocompatibility complex region in the Japanese population. Nat. Genet.51(3):470-480, 2019.
  28. Romero V, Nakaoka H, Hosomichi K, and Inoue I. High order formation and evolution of hornerin in primates. Genome Biol. Evol. 10(12):3167-3175, 2018.
  29. Takahashi K, Hayano T, Sugimoto R, Kashiwagi H, Shinoda M, Nishijima Y, Suzuki T, Suzuki S, Ohnuki Y, Kondo A, Shiina T, Nakaoka H, Inoue I, and Izumi SI. Exome and copy number variation analyses of Mayer-Rokitansky-Küster-Hauser syndrome. Hum. Genome Var. 5:27, 2018.
  30. Tamura R, Nakaoka H, Yoshihara K, Mori Y, Yachida N, Nishikawa N, Motoyama T, Okuda S, Inoue I, and Enomoto T. Novel MXD4-NUTM1 fusion transcript identified in primary ovarian undifferentiated small round cell sarcoma. Genes Chromosomes Cancer. 57(11): 557-563, 2018.
  31. Suda K*, Nakaoka H*, Yoshihara K, Ishiguro T, Tamura R, Mori Y, Yamawaki K, Adachi S, Takahashi T, Kase H, Tanaka K, Yamamoto T, Motoyama T, Inoue I, and Enomoto T. Clonal expansion and diversification of cancer-associated mutations in endometriosis and normal endometrium. Cell Rep. 24(7):1777-1789, 2018. *Co-first author.
  32. Yang YX, Wei L, Zhang YJ, Hayano T, Piñeiro Pereda MDP, Nakaoka H, Li Q, Barragán Mallofret I, Lu YZ, Tamagnone L, Inoue I, Li X, Luo JY, Zheng K, and You H. Long non-coding RNA p10247, high expressed in breast cancer (lncRNA-BCHE), is correlated with metastasis. Clin. Exp. Metastasis. 35(3):109-121, 2018.
  33. Sakiyama M, Matsuo H, Nakaoka H, Kawamura Y, Kawaguchi M, Higashino T, Nakayama A, Akashi A, Ueyama J, Kondo T, Wakai K, Sakurai Y, Yamamoto K, Ooyama H, and Shinomiya N. Common variant of BCAS3 is associated with gout risk in Japanese population : the first replication study after gout GWAS in Han Chinese. BMC Med. Genet. 19(1): 96, 2018.
  34. Ishimine M, Lee HC, Nakaoka H, Orita H, Kobayashi T, Mizuguchi K, Endo M, Inoue I, Sato K, and Yokomizo T. The relationship between TP53 gene status and carboxylesterase 2 expression in human colorectal cancer. Dis. Markers. 2018: 5280736, 2018.
  35. Tamura R, Yoshihara K, Saito T, Ishimura R, Martínez-Ledesma JE, Xin H, Ishiguro T, Mori Y, Yamawaki K, Suda K, Sato S, Itamochi H, Motoyama T, Aoki Y, Okuda S, Casingal CR, Nakaoka H, Inoue I, Verhaak RGW, Komatsu M, and Enomoto T. Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions. Oncogenesis. 7(1): 4, 2018.
  36. Higashino T*, Takada T*, Nakaoka H*, Toyoda Y, Stiburkova B, Miyata H, Ikebuchi Y, Nakashima H, Shimizu S, Kawaguchi M, Sakiyama M, Nakayama A, Akashi A, Tanahashi Y, Kawamura Y, Nakamura T, Wakai K, Okada R, Yamamoto K, Hosomichi K, Hosoya T, Ichida K, Ooyama H, Suzuki H, Inoue I, Merriman TR, Shinomiya N, and Matsuo H. Multiple common and rare variants of ABCG2 cause gout. RMD Open. 3(2): e000464, 2017.*Co-first author.
  37. Ito J, Sugimoto R, Nakaoka H, Yamada S, Kimura T, Hayano T, and Inoue I. Systematic identification and characterization of regulatory elements derived from human endogenous retroviruses. PLOS Genet. 13(7): e1006883, 2017.
  38. Matsumoto Y, Goto T, Nishino J, Nakaoka H, Tanave A, Takano-Shimizu T, Mott RF, and Koide T. Selective breeding and selection mapping using a novel wild-derived heterogeneous stock of mice revealed two closely-linked loci for tameness. Sci. Rep. 7(1): 4607, 2017.
  39. Nakayama A*, Nakaoka H*, Yamamoto K*, Sakiyama M*, Shaukat A*, Toyoda Y*, Okada Y, Kamatani Y, Nakamura T, Takada T, Inoue K, Yasujima T, Yuasa H, Shirahama Y, Nakashima H, Shimizu S, Higashino T, Kawamura Y, Ogata H, Kawaguchi M, Ohkawa Y, Danjoh I, Tokumasu A, Ito T, Kondo T, Wakai K, Stiburkova B, Pavelka K, Stamp LK, Dalbeth N, Eurogout Consortium, Sakurai Y, Suzuki H, Hosoyamada M, Fujimori S, Yokoo T, Hosoya T, Inoue I, Takahashi A, Kubo M, Ooyama H, Shimizu T, Ichida K, Shinomiya N, Merriman TR, and Matsuo H. GWAS of clinically-defined gout and subtypes identifies multiple susceptibility loci including transporter genes. Ann. Rheum. Dis. 76(5): 869-877, 2017. *Co-first authors.
  40. Ahmadloo S*, Nakaoka H*, Hayano T, Hosomichi K, You H, Utsuno E, Sangai T, Nishimura M, Matsushita K, Hata A, Nomura F, and Inoue I. Rapid and cost-effective high-throughput sequencing for identification of germline mutations of BRCA1 and BRCA2. J. Hum. Genet. 62(5): 561-567, 2017. *Co-first author.
  41. Yamaguchi T, Hosomichi K, Yano K, Kim YI, Nakaoka H, Kimura R, Otsuka H, Nonaka N, Haga S, Takahashi M, Shirota T, Kikkawa Y, Yamada A, Kamijo R, Park SB, Nakamura M, Maki K, and Inoue I. Comprehensive genetic exploration of selective tooth agenesis of mandibular incisors by exome sequencing. Hum. Genome Var. 4: 17005, 2017.
  42. Mori T, Hosomichi K, Chiga M, Mandai S, Nakaoka H, Sohara E, Okado T, Rai T, Sasaki S, Inoue I, and Uchida S. Comprehensive genetic testing approach for major inherited kidney diseases, using next-generation sequencing with a custom panel.Clin. Exp. Nephrol. 21(1): 63-75, 2017.
  43. Romero V, Hosomichi K, Nakaoka H, Shibata H, and Inoue I. Structure and evolution of the filaggrin gene repeated region in primates. BMC Evol. Biol. 17(1): 10, 2017.
  44. Hayano T, Matsui H, Nakaoka H, Ohtake N, Hosomichi K, Suzuki K, and Inoue I. Germline variants of prostate cancer in Japanese families. PLOS ONE. 11(10): e0164233, 2016.
  45. van ‘t Hof FN, Ruigrok YM, Lee CH, Ripke S, Anderson G, de Andrade M, Baas AF, Blankensteijn JD, Böttinger EP, Bown MJ, Broderick J, Bijlenga P, Carrell DS, Crawford DC, Crosslin DR, Ebeling C, Eriksson JG, Fornage M, Foroud T, von Und Zu Fraunberg M, Friedrich CM, Gaál EI, Gottesman O, Guo DC, Harrison SC, Hernesniemi J, Hofman A, Inoue I, Jääskeläinen JE, Jones GT, Kiemeney LA, Kivisaari R, Ko N, Koskinen S, Kubo M, Kullo IJ, Kuivaniemi H, Kurki MI, Laakso A, Lai D, Leal SM, Lehto H, LeMaire SA, Low SK, Malinowski J, McCarty CA, Milewicz DM, Mosley TH, Nakamura Y, Nakaoka H, Niemelä M, Pacheco J, Peissig PL, Pera J, Rasmussen-Torvik L, Ritchie MD, Rivadeneira F, van Rij AM, Santos-Cortez RL, Saratzis A, Slowik A, Takahashi A, Tromp G, Uitterlinden AG, Verma SS, Vermeulen SH, Wang GT; Aneurysm Consortium; Vascular Research Consortium of New Zealand, Han B, Rinkel GJ, and de Bakker PI. Shared genetic risk factors of intracranial, abdominal, and thoracic aneurysms. J. Am. Heart Assoc. 5(7): e002603, 2016.
  46. Sakiyama M, Matsuo H, Nakaoka H, Yamamoto K, Nakayama A, Nakamura T, Kawai S, Okada R, Ooyama H, Shimizu T, and Shinomiya N. Identification of rs671, a common variant of ALDH2, as a gout susceptibility locus. Sci. Rep. 6:25360, 2016.
  47. Nakaoka H, Gurumurthy A, Hayano T, Ahmadloo A, Omer WH, Yoshihara K, Yamamoto A, Kurose K, Enomoto T, Akira S, Hosomichi K, and Inoue I. Allelic imbalance in regulation of ANRIL through chromatin interaction at 9p21 endometriosis risk locus. PLOS Genet. 12(4): e1005893, 2016.
  48. Matsuo H*, Yamamoto K*, Nakaoka H*, Nakayama A*, Sakiyama M*, Chiba T, Takahashi A, Nakamura T, Nakashima H, Takada Y, Danjoh I, Shimizu S, Abe J, Kawamura Y, Terashige S, Ogata H, Tatsukawa S, Guang Y, Okada R, Morita E, Naito M, Tokumasu A, Onoue H, Iwaya K, Ito T, Takada T, Inoue K, Kato Y, Nakamura Y, Sakurai Y, Suzuki H, Kanai Y, Hosoya T, Hamajima N, Inoue I, Kubo M, Ichida K, Ooyama H, Shimizu T, and Shinomiya N. Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes. Ann. Rheum. Dis. 75(4): 652-659, 2016. *Co-first author.
  49. Rabbani B, Nakaoka H, Akhondzadeh S, Tekin M, and Mahdieh N. Next Generation Sequencing: Implications in personalized medicine and pharmacogenomics. Mol. Biosyst. 12(6): 1818-1830, 2016.

Before 2016 (selected)

  1. Nakaoka H and Inoue I. Distribution of HLA haplotypes across Japanese Archipelago: similarity, difference and admixture. J. Hum. Genet. 60(11): 683-690, 2015.
  2. Nakaoka H, Tajima A, Yoneyama T, Hosomichi K, Kasuya H, Mizutani T, and Inoue I. Gene expression profiling reveals distinct molecular signatures associated with the rupture of intracranial aneurysm. Stroke. 45(8): 2239-2245, 2014.
  3. Nakaoka H, Mitsunaga S, Hosomichi K, Shyh-Yuh L, Sawamoto T, Fujiwara T, Tsutsui N, Suematsu K, Shinagawa A, Inoko H, and Inoue I: Detection of ancestry informative HLA alleles confirms the admixed origins of Japanese population. PLOS ONE . 8(4): e60793, 2013.
  4. Nakaoka H, Cui T, Tajima A, Oka A, Mitsunaga S, Kashiwase K, Homma Y, Sato S, Suzuki Y, Inoko H, and Inoue I: A systems genetics approach provides a bridge from discovered genetic variants to biological pathways in rheumatoid arthritis. PLOS ONE . 6(9): e25389, 2011.
  5. Nakaoka H, Takahashi T, Akiyama K, Cui T, Tajima A, Krischek B, Kasuya H, Hata A, and Inoue I: Differential effects of chromosome 9p21 variation on subphenotypes of intracranial aneurysm: site distribution. Stroke. 41(8): 1593-1598, 2010.
  6. Nakaoka H and Inoue I: Meta-analysis of genetic association studies: methodologies, between-study heterogeneity and winner’s curse. J. Hum. Genet. 54(11): 615-623, 2009.